EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark MYOTRUVI was filed as Word mark on 12/03/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 04/20/2022.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018614729 |
| Application date | December 3, 2021 |
| Publication date | January 11, 2022 |
| Entry date | April 20, 2022 |
| Expiration date | December 3, 2031 |
Trademark owner
215 First Street
02142 Cambridge
US
02142 Cambridge
US
Trademark representatives
Ferdinand-Happ-Str. 32
60314 Frankfurt
DE
goods and services
5
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 11, 2023 | Change Representative, Published |
ID: 11018614729